| Host |
Mouse |
| Klon |
6F-H2 |
| Format |
Ready-to-use |
| Methode |
F, P |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
Wilm´s tumor |
| Verdünnung |
- |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cytoplasm, nucleus |
WT1 (Wilm's Tumor Protein-1)
|
Diagnostic Biosystems |
6F-H2 |
6 ml |
Ready-to-use |
CE/IVD |
PDM177 |
-
|
| Host |
Mouse |
| Klon |
6F-H2 |
| Format |
Ready-to-use |
| Methode |
F, P |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
Wilm´s tumor |
| Verdünnung |
- |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cytoplasm, nucleus |
WT1 (Wilm's Tumor Protein-1)
|
Diagnostic Biosystems |
6F-H2 |
25 ml |
Ready-to-use |
CE/IVD |
PDM177-25 |
-
|
| Host |
Mouse |
| Klon |
rWT1/857 |
| Format |
concentrate |
| Methode |
P |
| Vorbehandlung |
Citrate o EDTA |
| Positivkontrolle |
Wilms' tumor, mesothelioma, or normal kidney |
| Verdünnung |
1:100 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant full-length human WT1 protein |
| Lokalisation |
Nuclear and cytoplasmic |
WT1 [rWT1/857]
|
Biocare Medical |
rWT1/857 |
0.1 ml |
concentrate |
CE/IVD |
ACI3238A |
-
|
| Host |
Mouse |
| Klon |
rWT1/857 |
| Format |
concentrate |
| Methode |
P |
| Vorbehandlung |
Citrate o EDTA |
| Positivkontrolle |
Wilms' tumor, mesothelioma, or normal kidney |
| Verdünnung |
1:100 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant full-length human WT1 protein |
| Lokalisation |
Nuclear and cytoplasmic |
WT1 [rWT1/857]
|
Biocare Medical |
rWT1/857 |
1ml |
concentrate |
CE/IVD |
ACI3238C |
-
|
| Host |
Mouse |
| Klon |
rWT1/857 |
| Format |
ready-to-use |
| Methode |
P |
| Vorbehandlung |
Citrate o EDTA |
| Positivkontrolle |
Wilms' tumor, mesothelioma, or normal kidney |
| Verdünnung |
--- |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant full-length human WT1 protein |
| Lokalisation |
Nuclear and cytoplasmic |
WT1 [rWT1/857]
|
Biocare Medical |
rWT1/857 |
6ml |
ready-to-use |
CE/IVD |
API3238AA |
-
|
| Host |
Monospecific Mouse |
| Klon |
ZM97 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil, CLL/SLL. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant fragment of human ZAP70 protein (around aa247-382) |
| Lokalisation |
Cytoplasm |
ZAP-70
|
Zeta Corporation |
ZM97 |
1 ml |
Concentrate |
CE/IVD |
Z2407ML |
-
|
| Host |
Monospecific Mouse |
| Klon |
ZM97 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil, CLL/SLL. |
| Verdünnung |
- |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant fragment of human ZAP70 protein (around aa247-382) |
| Lokalisation |
Cytoplasm |
ZAP-70
|
Zeta Corporation |
ZM97 |
7 ml |
Ready-to-use |
CE/IVD |
Z2407MP |
-
|
| Host |
Monospecific Mouse |
| Klon |
ZM97 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil, CLL/SLL. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant fragment of human ZAP70 protein (around aa247-382) |
| Lokalisation |
Cytoplasm |
ZAP-70
|
Zeta Corporation |
ZM97 |
0.5 ml |
Concentrate |
CE/IVD |
Z2407MS |
-
|
| Host |
Monospecific Mouse |
| Klon |
ZM97 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil, CLL/SLL. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant fragment of human ZAP70 protein (around aa247-382) |
| Lokalisation |
Cytoplasm |
ZAP-70
|
Zeta Corporation |
ZM97 |
0.1 ml |
Concentrate |
CE/IVD |
Z2407MT |
-
|